{"transactions":[{"id":1219465,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T00:17:15.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":23726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year from March 4, 2025, subject to continued service as a director through such vesting dates."}],"balance_after":23726,"derivative":{"exercise_price":8.12,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":23726},"source":{"system":"sec-edgar","filing":"0001062993-25-004807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004807/form4.xml","form_type":"4"}},{"id":1219464,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T00:17:15.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":15394,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":69690,"source":{"system":"sec-edgar","filing":"0001062993-25-004807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004807/form4.xml","form_type":"4"}},{"id":1246524,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:07:01.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3333,"price":8.84,"value":29463.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of the Effective Time, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":11.16,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0000950170-25-027099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027099/ownership.xml","form_type":"4"}},{"id":1246523,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:07:01.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of the Effective Time, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":31.8,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0000950170-25-027099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027099/ownership.xml","form_type":"4"}},{"id":1246522,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:07:01.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of the Effective Time, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":85.8,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0000950170-25-027099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027099/ownership.xml","form_type":"4"}},{"id":1246521,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-25T20:07:01.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of the Effective Time, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, and after giving effect to the acceleration treatment set forth in footnote (4), each vested stock option was cancelled and automatically converted into the right to receive an amount in cash determined by multiplying (x) the excess, if any, of the Merger Consideration over the applicable exercise price of such option by (y) the number of vested shares subject to such option (the \"Option Payment\"), less all applicable deductions and withholdings; provided, however, that the Option Payment for each option with an exercise price equal to or greater than $20.00 was $0 and such option was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":672.9,"expiration_date":"2031-05-05","underlying":"Common Stock","underlying_shares":916},"source":{"system":"sec-edgar","filing":"0000950170-25-027099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027099/ownership.xml","form_type":"4"}},{"id":1246520,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-25T20:07:01.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":324388,"ownership":{"direct":false,"nature":"By The Pellini Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were disposed of pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, whereby, at the effective time of the merger contemplated therein (the \"Effective Time\"), all issued and outstanding shares of Issuer common stock were cancelled and automatically converted into the right to receive $20.00 per share in cash, without interest, less all applicable deductions and withholdings (the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the trustee of The Pellini Family Trust and has voting and dispositive power with respect to these shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-027099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027099/ownership.xml","form_type":"4"}},{"id":1246519,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-25T20:07:01.000Z","date":"2025-02-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were disposed of pursuant to the Agreement and Plan of Merger, dated as of December 22, 2024 (the \"Merger Agreement\"), by and among the Issuer, Singular Genomics Parent, LLC, a Delaware limited liability company, and Saturn Merger Sub, Inc., a Delaware corporation, whereby, at the effective time of the merger contemplated therein (the \"Effective Time\"), all issued and outstanding shares of Issuer common stock were cancelled and automatically converted into the right to receive $20.00 per share in cash, without interest, less all applicable deductions and withholdings (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-027099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017025027099/ownership.xml","form_type":"4"}},{"id":1496792,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T18:30:06.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable upon the earlier of the 2025 Annual Meeting of Stockholders or May 29, 2025."}],"balance_after":100000,"derivative":{"exercise_price":0.372,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-067529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000095017024067529/ownership.xml","form_type":"4"}},{"id":1591573,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-07T00:46:07.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":48044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year from March 4, 2024, subject to continued service as a director through such vesting dates."}],"balance_after":48044,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":48044},"source":{"system":"sec-edgar","filing":"0001062993-24-005775","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005775/form4.xml","form_type":"4"}},{"id":1591572,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-07T00:46:07.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":31328,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":54296,"source":{"system":"sec-edgar","filing":"0001062993-24-005775","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005775/form4.xml","form_type":"4"}},{"id":1876707,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T17:04:46.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable upon the earlier of the 2024 Stockholder Annual Meeting or May 25, 2024."}],"balance_after":100000,"derivative":{"exercise_price":1.06,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-032603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919123032603/doc4.xml","form_type":"4"}},{"id":1963195,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:08:48.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":23329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates."}],"balance_after":23329,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":23329},"source":{"system":"sec-edgar","filing":"0001062993-23-006337","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006337/form4.xml","form_type":"4"}},{"id":1963194,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T01:08:48.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":14775,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22968,"source":{"system":"sec-edgar","filing":"0001062993-23-006337","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006337/form4.xml","form_type":"4"}},{"id":2038689,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T18:49:25.000Z","date":"2022-02-10","kind":"gift","acquired":false,"shares":72455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the gift of shares by the Reporting Person to The Pellini Family Trust."}],"balance_after":26834,"source":{"system":"sec-edgar","filing":"0001209191-23-005999","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919123005999/doc5.xml","form_type":"5"}},{"id":2135643,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-10-18T22:37:19.000Z","date":"2022-10-15","kind":"exercise","acquired":false,"shares":4278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":8558,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4278},"source":{"system":"sec-edgar","filing":"0001209191-22-054001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122054001/doc4.xml","form_type":"4"}},{"id":2135642,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-10-18T22:37:19.000Z","date":"2022-10-15","kind":"exercise","acquired":true,"shares":4278,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":17114,"source":{"system":"sec-edgar","filing":"0001209191-22-054001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122054001/doc4.xml","form_type":"4"}},{"id":2240403,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T07:30:14.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.63,"exercise_date":"2019-12-17","expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-034752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122034752/doc4.xml","form_type":"4"}},{"id":2240402,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T07:30:14.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":34271,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.235,"exercise_date":"2018-12-12","expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":34271},"source":{"system":"sec-edgar","filing":"0001209191-22-034752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122034752/doc4.xml","form_type":"4"}},{"id":2240401,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T07:30:14.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":60668,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.2108,"exercise_date":"2017-09-15","expiration_date":"2027-09-14","underlying":"Common Stock","underlying_shares":60668},"source":{"system":"sec-edgar","filing":"0001209191-22-034752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122034752/doc4.xml","form_type":"4"}},{"id":2240400,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T07:30:14.000Z","date":"2022-05-31","kind":"gift","acquired":false,"shares":154939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately upon exercise of the Reporting Person's options, the Reporting Person transferred his shares as a gift to The Pellini Family Trust."}],"balance_after":99289,"source":{"system":"sec-edgar","filing":"0001209191-22-034752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122034752/doc4.xml","form_type":"4"}},{"id":2240399,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T07:30:14.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":60000,"price":0.63,"value":37800.0,"ownership":{"direct":true},"balance_after":254228,"source":{"system":"sec-edgar","filing":"0001209191-22-034752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122034752/doc4.xml","form_type":"4"}},{"id":2240398,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T07:30:14.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":34271,"price":0.235,"value":8053.685,"ownership":{"direct":true},"balance_after":194228,"source":{"system":"sec-edgar","filing":"0001209191-22-034752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122034752/doc4.xml","form_type":"4"}},{"id":2240397,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T07:30:14.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":60668,"price":0.2108,"value":12788.8144,"ownership":{"direct":true},"balance_after":159957,"source":{"system":"sec-edgar","filing":"0001209191-22-034752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122034752/doc4.xml","form_type":"4"}},{"id":2251607,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T21:04:10.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest and become exercisable upon the earlier of the 2023 Stockholder Annual Meeting or May 26, 2023."}],"balance_after":62500,"derivative":{"exercise_price":2.86,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-22-033019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122033019/doc4.xml","form_type":"4"}},{"id":2263983,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T17:01:02.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":26834,"price":3.3,"value":88552.2,"ownership":{"direct":true},"balance_after":99289,"source":{"system":"sec-edgar","filing":"0001209191-22-030584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919122030584/doc4.xml","form_type":"4"}},{"id":2273616,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-13T00:24:44.000Z","date":"2022-04-27","kind":"exercise","acquired":false,"shares":12836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the date of the next annual meeting of the Company's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the non-employee director continues to provide services to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the date of the next annual meeting of the Company's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the non-employee director continues to provide services to the Company through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12836},"source":{"system":"sec-edgar","filing":"0001209191-22-028693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122028693/doc4.xml","form_type":"4"}},{"id":2273615,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-05-13T00:24:44.000Z","date":"2022-04-27","kind":"exercise","acquired":true,"shares":12836,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":12836,"source":{"system":"sec-edgar","filing":"0001209191-22-028693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122028693/doc4.xml","form_type":"4"}},{"id":2279417,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-06T23:04:43.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":78914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4 amendment has been filed solely to correct the exercise price of a previously issued stock option to purchase shares of Class A Common Stock of the Issuer reported in a Form 4 filed on May 4, 2022 (the \"Form 4\"). The exercise price was inadvertently stated as $2.155 in the Form 4. The exercise price should have been stated as $2.20 in the Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":78914,"derivative":{"exercise_price":2.2,"expiration_date":"2032-05-01","underlying":"Class A Common Stock","underlying_shares":78914},"source":{"system":"sec-edgar","filing":"0001209191-22-027693","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122027693/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-04"}},{"id":2282455,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-05T00:33:46.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":45454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The underlying shares shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":45454,"derivative":{"underlying":"Class A Common Stock","underlying_shares":45454},"source":{"system":"sec-edgar","filing":"0001209191-22-027290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122027290/doc4.xml","form_type":"4"}},{"id":2282454,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-05T00:33:46.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":78914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":78914,"derivative":{"exercise_price":2.155,"expiration_date":"2032-05-01","underlying":"Class A Common Stock","underlying_shares":78914},"source":{"system":"sec-edgar","filing":"0001209191-22-027290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122027290/doc4.xml","form_type":"4"}},{"id":2422479,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-29T00:00:47.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":16722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."}],"balance_after":16722,"derivative":{"exercise_price":14.95,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":16722},"source":{"system":"sec-edgar","filing":"0001209191-22-005499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122005499/doc4.xml","form_type":"4"}},{"id":2422478,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-29T00:00:47.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":6689,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8193,"source":{"system":"sec-edgar","filing":"0001209191-22-005499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122005499/doc4.xml","form_type":"4"}},{"id":2539469,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-10-19T23:27:37.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":12836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs will vest in equal annual installments over the three-year period following the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":12836,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12836},"source":{"system":"sec-edgar","filing":"0001209191-21-061029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121061029/doc4.xml","form_type":"4"}},{"id":2539468,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-10-19T23:27:37.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":12836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options and restricted stock units (\"RSUs\") will vest on the earlier of (i) the date of the next annual meeting of the Issuer's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the Reporting Person continues to provide services to the Issuer through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options and restricted stock units (\"RSUs\") will vest on the earlier of (i) the date of the next annual meeting of the Issuer's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the Reporting Person continues to provide services to the Issuer through such vesting date."}],"balance_after":12836,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12836},"source":{"system":"sec-edgar","filing":"0001209191-21-061029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121061029/doc4.xml","form_type":"4"}},{"id":2539467,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-19T23:27:37.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":22286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest as of 1/36 of the total shares monthly beginning on November 15, 2021 until fully vested, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date."}],"balance_after":22286,"derivative":{"exercise_price":7.79,"expiration_date":"2031-10-14","underlying":"Class A Common Stock","underlying_shares":22286},"source":{"system":"sec-edgar","filing":"0001209191-21-061029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121061029/doc4.xml","form_type":"4"}},{"id":2539466,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-19T23:27:37.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":22286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options and restricted stock units (\"RSUs\") will vest on the earlier of (i) the date of the next annual meeting of the Issuer's shareholders following the grant date and (i) the first anniversary of the grant date, in each case so long as the Reporting Person continues to provide services to the Issuer through such vesting date."}],"balance_after":22286,"derivative":{"exercise_price":7.79,"expiration_date":"2031-10-14","underlying":"Class A Common Stock","underlying_shares":22286},"source":{"system":"sec-edgar","filing":"0001209191-21-061029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121061029/doc4.xml","form_type":"4"}},{"id":2689195,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-06-01T21:45:58.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":96944,"ownership":{"direct":false,"nature":"By The Pellini Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of the Series A Preferred Stock (the \"Preferred Stock\") automatically converted into shares of the Issuer's common stock, par value $0.0001 per share, on a one-for-one basis.  The shares of Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of the Series A Preferred Stock (the \"Preferred Stock\") automatically converted into shares of the Issuer's common stock, par value $0.0001 per share, on a one-for-one basis.  The shares of Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of the Series A Preferred Stock (the \"Preferred Stock\") automatically converted into shares of the Issuer's common stock, par value $0.0001 per share, on a one-for-one basis.  The shares of Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of the Series A Preferred Stock (the \"Preferred Stock\") automatically converted into shares of the Issuer's common stock, par value $0.0001 per share, on a one-for-one basis.  The shares of Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the trustee of The Pellini Family Trust and has voting and dispositive power with respect to these shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":96944},"source":{"system":"sec-edgar","filing":"0001209191-21-037021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919121037021/doc4.xml","form_type":"4"}},{"id":2689194,"issuer":{"id":82741,"kind":"organization","name":"Singular Genomics Systems, Inc.","symbol":"OMIC"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-01T21:45:58.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":96944,"ownership":{"direct":false,"nature":"By The Pellini Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of the Series A Preferred Stock (the \"Preferred Stock\") automatically converted into shares of the Issuer's common stock, par value $0.0001 per share, on a one-for-one basis.  The shares of Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the trustee of The Pellini Family Trust and has voting and dispositive power with respect to these shares."}],"balance_after":96944,"source":{"system":"sec-edgar","filing":"0001209191-21-037021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850906/000120919121037021/doc4.xml","form_type":"4"}},{"id":2796890,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T00:00:23.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on February 7, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":55000,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-019622","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121019622/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-03"}},{"id":2796889,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T00:00:23.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":20000,"price":57.8,"value":1156000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $57.75 to 58.19, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-019622","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121019622/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-03"}},{"id":2796888,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T00:00:23.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":20000,"price":6.55,"value":131000.0,"ownership":{"direct":true},"balance_after":21504,"source":{"system":"sec-edgar","filing":"0001209191-21-019622","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121019622/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-03"}},{"id":2813100,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T00:00:17.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on February 7, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":55000,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-017304","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017304/doc4.xml","form_type":"4"}},{"id":2813099,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-04T00:00:17.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":20000,"price":57.8,"value":1156000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $57.75 to 58.19, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-017304","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017304/doc4.xml","form_type":"4"}},{"id":2813098,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-04T00:00:17.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":20000,"price":6.55,"value":131000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-017304","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121017304/doc4.xml","form_type":"4"}},{"id":2854457,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T01:00:33.000Z","date":"2021-02-14","kind":"grant","acquired":true,"shares":3759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."}],"balance_after":3759,"derivative":{"exercise_price":66.5,"expiration_date":"2031-02-14","underlying":"Common Stock","underlying_shares":3759},"source":{"system":"sec-edgar","filing":"0001209191-21-011546","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011546/doc4.xml","form_type":"4"}},{"id":2854456,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T01:00:33.000Z","date":"2021-02-14","kind":"grant","acquired":true,"shares":1504,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-011546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011546/doc4.xml","form_type":"4"}},{"id":2932862,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-24T00:00:08.000Z","date":"2020-12-21","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on February 7, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":75000,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-065102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120065102/doc4.xml","form_type":"4"}},{"id":2932861,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-24T00:00:08.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":25000,"price":60,"value":1500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-065102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120065102/doc4.xml","form_type":"4"}},{"id":2932860,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-24T00:00:08.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":25000,"price":6.55,"value":163750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2020."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-20-065102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120065102/doc4.xml","form_type":"4"}},{"id":3005215,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-16T21:00:13.000Z","date":"2020-10-14","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on February 7, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":100000,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-055068","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120055068/doc4.xml","form_type":"4"}},{"id":3005214,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T21:00:13.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":21745,"price":52.95,"value":1151397.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $52.59 to 53.36, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-055068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120055068/doc4.xml","form_type":"4"}},{"id":3005213,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T21:00:13.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":28255,"price":51.89,"value":1466151.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $51.49 to 52.435, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":21745,"source":{"system":"sec-edgar","filing":"0001209191-20-055068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120055068/doc4.xml","form_type":"4"}},{"id":3005212,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T21:00:13.000Z","date":"2020-10-14","kind":"exercise","acquired":true,"shares":50000,"price":6.55,"value":327500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2020."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-20-055068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120055068/doc4.xml","form_type":"4"}},{"id":3266740,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-18T12:05:36.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."}],"balance_after":8888,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0001209191-20-009869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120009869/doc4.xml","form_type":"4"}},{"id":3855000,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"stock option (right to buy)","published_at":"2018-08-02T16:09:00.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":25625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option was granted on May 21, 2013 and vested in equal quarterly installments over four years until fully vested. All unvested stock options accelerated and became 100% vested in connection with the completion of a tender offer by Roche on April 7, 2015."}],"balance_after":0,"derivative":{"exercise_price":7.12,"expiration_date":"2023-05-21","underlying":"Common Stock","underlying_shares":25625},"source":{"system":"sec-edgar","filing":"0001209191-18-044933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044933/doc4.xml","form_type":"4"}},{"id":3854999,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"stock option (right to buy)","published_at":"2018-08-02T16:09:00.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":49224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option was granted on March 7, 2013 and vested in equal quarterly installments over four years until fully vested. All unvested stock options accelerated and became 100% vested in connection with the completion of a tender offer by Roche on April 7, 2015."}],"balance_after":0,"derivative":{"exercise_price":4.16,"expiration_date":"2023-03-07","underlying":"Common Stock","underlying_shares":49224},"source":{"system":"sec-edgar","filing":"0001209191-18-044933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044933/doc4.xml","form_type":"4"}},{"id":3854998,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"stock option (right to buy)","published_at":"2018-08-02T16:09:00.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":30548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option was granted on March 27, 2012 and vested 25% after one year and then in equal quarterly installments over three years until fully vested. All unvested stock options accelerated and became 100% vested in connection with the completion of a tender offer by Roche on April 7, 2015."}],"balance_after":0,"derivative":{"exercise_price":0.84,"expiration_date":"2022-03-27","underlying":"Common Stock","underlying_shares":30548},"source":{"system":"sec-edgar","filing":"0001209191-18-044933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044933/doc4.xml","form_type":"4"}},{"id":3854997,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"stock option (right to buy)","published_at":"2018-08-02T16:09:00.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":6949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option was granted on January 10, 2012 and vested 25% after one year and then in equal quarterly installments over three years until fully vested. All unvested stock options accelerated and became 100% vested in connection with the completion of a tender offer by Roche on April 7, 2015."}],"balance_after":0,"derivative":{"exercise_price":0.84,"expiration_date":"2022-01-10","underlying":"Common Stock","underlying_shares":6949},"source":{"system":"sec-edgar","filing":"0001209191-18-044933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044933/doc4.xml","form_type":"4"}},{"id":3854996,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:09:00.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":103711,"price":137,"value":14208407.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount reported represents the number of shares sold by the reporting person in connection with the Tender Offer by Roche."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-044933","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044933/doc4.xml","form_type":"4"}},{"id":3888701,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-19T16:03:21.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":3500,"price":105.45,"value":369075.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."}],"balance_after":103711,"source":{"system":"sec-edgar","filing":"0001209191-18-038514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118038514/doc4.xml","form_type":"4"}},{"id":3928129,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T16:12:57.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":3500,"price":76.05,"value":266175.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."}],"balance_after":107211,"source":{"system":"sec-edgar","filing":"0001209191-18-030879","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118030879/doc4.xml","form_type":"4"}},{"id":3961041,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-18T16:08:15.000Z","date":"2018-04-16","kind":"sale","acquired":false,"shares":3500,"price":74.65,"value":261275.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.00 to $80.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":110711,"source":{"system":"sec-edgar","filing":"0001209191-18-025355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118025355/doc4.xml","form_type":"4"}},{"id":3968415,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-05T16:14:43.000Z","date":"2018-04-03","kind":"sale","acquired":false,"shares":13659,"price":70.28,"value":959954.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.95 to $73.35, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":114211,"source":{"system":"sec-edgar","filing":"0001209191-18-024046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118024046/doc4.xml","form_type":"4"}},{"id":3989567,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-19T16:18:24.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":3500,"price":78.29,"value":274015.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.50 to $79.45, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":127870,"source":{"system":"sec-edgar","filing":"0001209191-18-020568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118020568/doc4.xml","form_type":"4"}},{"id":4047600,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-20T16:04:58.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":17324,"price":67.69,"value":1172661.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.55 to $68.93, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001209191-18-011250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118011250/doc4.xml","form_type":"4"}},{"id":4096169,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-18T16:04:57.000Z","date":"2018-01-17","kind":"sale","acquired":false,"shares":10150,"price":65.52,"value":665028.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.20 to $66.95, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":148694,"source":{"system":"sec-edgar","filing":"0001209191-18-004230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004230/doc4.xml","form_type":"4"}},{"id":4096168,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-18T16:04:57.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":27138,"price":64.19,"value":1741988.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.65 to $68.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":158844,"source":{"system":"sec-edgar","filing":"0001209191-18-004230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118004230/doc4.xml","form_type":"4"}},{"id":4130345,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-15T16:03:18.000Z","date":"2017-12-13","kind":"sale","acquired":false,"shares":48746,"price":61.71,"value":3008115.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on December 12, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported restricted stock units granted to the reporting person on December 15, 2015 in Table I of the Form 4 filed on December 23, 2015. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":185982,"source":{"system":"sec-edgar","filing":"0001209191-17-065891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117065891/doc4.xml","form_type":"4"}},{"id":4130344,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-15T16:03:18.000Z","date":"2017-12-07","kind":"gift","acquired":false,"shares":2500,"price":62.25,"value":155625.0,"ownership":{"direct":true},"balance_after":234728,"source":{"system":"sec-edgar","filing":"0001209191-17-065891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117065891/doc4.xml","form_type":"4"}},{"id":4139214,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-07T16:04:58.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":20947,"price":58.11,"value":1217230.17,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.30 to $58.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":237228,"source":{"system":"sec-edgar","filing":"0001209191-17-064397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117064397/doc4.xml","form_type":"4"}},{"id":4139213,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-07T16:04:58.000Z","date":"2017-12-05","kind":"sale","acquired":false,"shares":9053,"price":61.47,"value":556487.91,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.00 to $62.43, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":258175,"source":{"system":"sec-edgar","filing":"0001209191-17-064397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117064397/doc4.xml","form_type":"4"}},{"id":4192154,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T16:04:47.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":4349,"price":38.8,"value":168741.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on October 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.46 to $38.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":267228,"source":{"system":"sec-edgar","filing":"0001209191-17-055746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117055746/doc4.xml","form_type":"4"}},{"id":4237813,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-10T16:06:59.000Z","date":"2017-08-09","kind":"gift","acquired":false,"shares":3500,"price":39.15,"value":137025.0,"ownership":{"direct":true},"balance_after":271577,"source":{"system":"sec-edgar","filing":"0001209191-17-048411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117048411/doc4.xml","form_type":"4"}},{"id":4237812,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-10T16:06:59.000Z","date":"2017-08-09","kind":"sale","acquired":false,"shares":30000,"price":39.52,"value":1185600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.05 to $40.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":275077,"source":{"system":"sec-edgar","filing":"0001209191-17-048411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117048411/doc4.xml","form_type":"4"}},{"id":4260876,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-07T16:03:57.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":4296,"price":38.84,"value":166856.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":305077,"source":{"system":"sec-edgar","filing":"0001209191-17-044361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044361/doc4.xml","form_type":"4"}},{"id":4260875,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-07T16:03:57.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":11560,"price":38.84,"value":448990.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on June 30, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $36.85 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on July 15, 2015 in Table I of the Form 4 filed on July 17, 2015. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":309373,"source":{"system":"sec-edgar","filing":"0001209191-17-044361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117044361/doc4.xml","form_type":"4"}},{"id":4358233,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-05T16:06:57.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":1700,"price":31.96,"value":54332.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on April 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":320933,"source":{"system":"sec-edgar","filing":"0001209191-17-025579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117025579/doc4.xml","form_type":"4"}},{"id":4392689,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"stock option (right to buy)","published_at":"2017-03-09T16:10:58.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":9489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option was granted on May 21, 2013 and vested in full on April 7, 2015."}],"balance_after":25625,"derivative":{"exercise_price":7.12,"expiration_date":"2023-05-21","underlying":"common stock","underlying_shares":9489},"source":{"system":"sec-edgar","filing":"0001209191-17-019588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117019588/doc4.xml","form_type":"4"}},{"id":4392688,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"stock option (right to buy)","published_at":"2017-03-09T16:10:58.000Z","date":"2017-03-07","kind":"exercise","acquired":false,"shares":30511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option was granted on May 21, 2013 and vested in full on April 7, 2015."}],"balance_after":35114,"derivative":{"exercise_price":7.12,"expiration_date":"2023-05-21","underlying":"common stock","underlying_shares":30511},"source":{"system":"sec-edgar","filing":"0001209191-17-019588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117019588/doc4.xml","form_type":"4"}},{"id":4392687,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-09T16:10:58.000Z","date":"2017-03-08","kind":"sale","acquired":false,"shares":9489,"price":34.28,"value":325282.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.05 to $34.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":322633,"source":{"system":"sec-edgar","filing":"0001209191-17-019588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117019588/doc4.xml","form_type":"4"}},{"id":4392686,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-09T16:10:58.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":9489,"price":7.12,"value":67561.68,"ownership":{"direct":true},"balance_after":332122,"source":{"system":"sec-edgar","filing":"0001209191-17-019588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117019588/doc4.xml","form_type":"4"}},{"id":4392685,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-09T16:10:58.000Z","date":"2017-03-07","kind":"sale","acquired":false,"shares":30511,"price":34.31,"value":1046832.41,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.30 to $34.35, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":322633,"source":{"system":"sec-edgar","filing":"0001209191-17-019588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117019588/doc4.xml","form_type":"4"}},{"id":4392684,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-09T16:10:58.000Z","date":"2017-03-07","kind":"exercise","acquired":true,"shares":30511,"price":7.12,"value":217238.32,"ownership":{"direct":true},"balance_after":353144,"source":{"system":"sec-edgar","filing":"0001209191-17-019588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117019588/doc4.xml","form_type":"4"}},{"id":4498513,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-05T16:09:27.000Z","date":"2017-01-04","kind":"sale","acquired":false,"shares":3491,"price":18.49,"value":64548.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on January 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":322633,"source":{"system":"sec-edgar","filing":"0001209191-17-001979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117001979/doc4.xml","form_type":"4"}},{"id":4498512,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-05T16:09:27.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":11146,"price":17.41,"value":194051.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on December 30, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $17.41 to $17.56, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on July 15, 2015 in Table I of the Form 4 filed on July 17, 2015. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":326124,"source":{"system":"sec-edgar","filing":"0001209191-17-001979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117001979/doc4.xml","form_type":"4"}},{"id":4584417,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":82293,"kind":"person","name":"Pellini Michael J","position":1,"cik":"0001402017","reported_name":"Pellini Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-10-05T16:08:32.000Z","date":"2016-10-04","kind":"sale","acquired":false,"shares":2629,"price":23.65,"value":62175.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on October 1, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $23.31 to $23.72, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":337270,"source":{"system":"sec-edgar","filing":"0001209191-16-144877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919116144877/doc4.xml","form_type":"4"}}]}